American Journal of Ophthalmology
Volume 146, Issue 3 , Pages 369-374.e1 , September 2008

Progression and Timing of Treatment of Zone I Retinopathy of Prematurity

  • Yuka Soh
    • ,
  • Takahiro Fujino
    • ,
  • Yoshikazu Hatsukawa

      Affiliations

    • Corresponding Author InformationInquiries to Yoshikazu Hatsukawa, Eye Department, Osaka Medical Center and Research Institute for Maternal and Child Health, 840 Murodo-cho, Izumi, Osaka 594–1101, Japan

,Accepted 5 May 2008.

References 

  1. Steinkuller PG, Gilbert C, Foster A, Collins ML, Coats DK. Childhood blindness. J AAPOS. 1999;3:26–32
  2. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity: preliminary results. Arch Ophthalmol. 1988;106:471–479
  3. Early Treatment for Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity:results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol. 2003;121:1684–1694
  4. International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol. 2005;123:991–999
  5. Morizane H. Initial sign and clinical course of the most severe form of acute proliferative retrolental fibroplasias (type 1) [in Japanese]. Nippon Ganka Gakkai Zasshi. 1976;80:54–61
  6. Kychenthal A, Dorta P, Katz X. Zone I retinopathy of prematurity clinical characteristics and treatment outcomes. Retina. 2006;26:S11–S15
  7. O'Keefe M, Lanigan B, Long VW. Outcome of zone I retinopathy of prematurity. Acta Ophthalmol Scand. 2003;81:614–616
  8. Onofrey CB, Feuer WJ, Flynn JT. The outcome of retinopathy of prematurity. Ophthalmology. 2001;108:27–35
  9. Hatsukawa Y, Ueki N, Yamagishi T, Kiytajima H. The effect of early treatment at the initial stage 3 moderate phase of retinopathy of prematurity on severe retinal changes. Jpn J Ophthalmol. 2005;49:391–396
  10. Schulenburg WE, Prendiville A, Ohri R. Natural history of retinopathy of prematurity. Br J Ophthalmol. 1987;71:837–843
  11. Blayney M, Clarke WN. Persistent tunica vasculosa lentis as a sign of congenital myotonic dystrophy. J Pediatr Ophthalmol Strabismus. 1994;31:384–386
  12. Kirwan C, O'Keefe M, Fitzsimon S. Central corneal thickness and corneal diameter in premature infants. Acta Ophthalmol Scand. 2005;83:751–753
  13. Al-Umran KU, Pandolfi MF. Corneal diameter in premature infants. Br J Ophthalmol. 1992;76:292–293
  14. Capone A, Diaz-Rohena R, Sternberg P, Mandell B, Lambert HM, Lopez PF. Diode-laser photocoagulation for zone I threshold retinopathy of prematurity. Am J Ophthalmol. 1993;116:444–450
  15. Fleming TN, Runge PE, Charles ST. Diode laser photocoagulation for prethreshold, posterior retinopathy of prematurity. Am J Ophthalmol. 1992;114:589–592
  16. Nissenkorn I, Kremer I, Gilad E, Cohen S, Ben-Sira I. ‘Rush’ type retinopathy of prematurity:report of three cases. Br J Ophthalmol. 1987;71:559–562
  17. Katz X, Kychenthal A, Dorta P. Zone I retinopathy of prematurity. J AAPOS. 2000;4:373–376
  18. Axer-Siegel R, Snir M, Cotlear D, et al. Diode laser treatment of posterior retinopathy of prematurity. Br J Ophthalmol. 2000;84:1383–1386
  19. Vander JF, Handa J, McNamara JA, et al. Early treatment of posterior retinopathy of prematurity: a controlled trial. Ophthalmology. 1997;104:1731–1736
  20. Recsan Z, Vamos R, Salacz G. Laser treatment of zone I prethreshold and stage 3 threshold retinopathy of prematurity. J Pediatr Ophthalmol Strabismus. 2003;40:204–207
  21. Hardy RJ, Palmer EA, Dobson V, et al. Cryotherapy for Retinopathy of Prematurity Cooperative Group Risk analysis of prethreshold retinopathy of prematurity. Arch Ophthalmol. 2003;121:1697–1701
  22. Foroozan R, Connolly BP, Tasman WS. Outcomes after laser therapy for threshold retinopathy of prematurity. Ophthalmology. 2001;108:1644–1646
  23. O'Keefe M, Burke J, Algawik K, Goggin M. Diode laser photocoagulation to the vascular retina for progressively advancing retinopathy of prematurity. Br J Ophthalmol. 1995;79:1012–1014
  24. Sternberg P, Lopez PF, Lambert HM, Aaberg TM, Capone A. Controversies in the management of retinopathy of prematurity. Am J Ophthalmol. 1992;113:198–202
  25. Paysse EA, Hussein MA, Miller AM, Brady McCreery KM, Coats DK. Pulsed mode versus near-continuous mode delivery of diode laser photocoagulation for high-risk retinopathy of prematurity. J AAPOS. 2007;11:388–392
  26. Noonan CP, Clark DI. Trends in the management of stage 3 retinopathy of prematurity. Br J Ophthalmol. 1996;80:278–281
  27. Flynn JT. Impact of the cryotherapy for retinopathy of prematurity randomized clinical trial. Arch Ophthalmol. 2007;125:1275–1276

PII: S0002-9394(08)00375-9

doi: 10.1016/j.ajo.2008.05.010

American Journal of Ophthalmology
Volume 146, Issue 3 , Pages 369-374.e1 , September 2008

Article Tools

* Image Usage & Resolution